AU2002353764A1 - Staphylococci surface-exposed immunogenic polypeptides - Google Patents
Staphylococci surface-exposed immunogenic polypeptidesInfo
- Publication number
- AU2002353764A1 AU2002353764A1 AU2002353764A AU2002353764A AU2002353764A1 AU 2002353764 A1 AU2002353764 A1 AU 2002353764A1 AU 2002353764 A AU2002353764 A AU 2002353764A AU 2002353764 A AU2002353764 A AU 2002353764A AU 2002353764 A1 AU2002353764 A1 AU 2002353764A1
- Authority
- AU
- Australia
- Prior art keywords
- staphylococci
- immunogenic polypeptides
- exposed
- exposed immunogenic
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000295644 Staphylococcaceae Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29897501P | 2001-06-17 | 2001-06-17 | |
| US60/298,975 | 2001-06-17 | ||
| PCT/US2002/019224 WO2003020875A2 (en) | 2001-06-17 | 2002-06-17 | Staphylococci surface-exposed immunogenic polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002353764A1 true AU2002353764A1 (en) | 2003-03-18 |
Family
ID=23152805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002353764A Abandoned AU2002353764A1 (en) | 2001-06-17 | 2002-06-17 | Staphylococci surface-exposed immunogenic polypeptides |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002353764A1 (en) |
| WO (1) | WO2003020875A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003006672A2 (en) * | 2001-07-10 | 2003-01-23 | D-Squared Biotechnologies, Inc. | Antimicrobial nucleic acid antibodies, and materials and methods for making and using same |
| EP1678316B1 (en) | 2003-09-19 | 2011-08-17 | Epitopix, LLC | Campylobacter polypeptides and methods of use |
| AU2005297171A1 (en) * | 2004-09-08 | 2006-04-27 | The University Of Western Ontario | Screening assays for inhibitors of a Staphylococcus aureus siderophore |
| RU2419628C2 (en) * | 2004-09-22 | 2011-05-27 | ГлаксоСмитКлайн Байолоджикалз с.а. | Immunogenic composition for use in vaccination against staphylococci |
| NZ560612A (en) * | 2005-02-14 | 2011-01-28 | Epitopix Llc | Polypeptides from staphylococcus aureus and methods of use |
| AU2015258239B2 (en) * | 2005-02-14 | 2017-08-17 | Epitopix, Llc | Polypeptides from staphylococcus aureus and methods of use |
| AU2012244060B2 (en) * | 2005-02-14 | 2015-08-20 | Epitopix, Llc | Polypeptides from staphylococcus aureus and methods of use |
| NZ614557A (en) * | 2009-03-23 | 2015-03-27 | Epitopix Llc | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| SI2510947T1 (en) * | 2009-04-14 | 2016-05-31 | Glaxosmithkline Biologicals S.A. | Compositions for immunising against Staphylococcus aureus |
| WO2015082536A1 (en) * | 2013-12-03 | 2015-06-11 | Evaxion Biotech Aps | Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus |
-
2002
- 2002-06-17 WO PCT/US2002/019224 patent/WO2003020875A2/en not_active Application Discontinuation
- 2002-06-17 AU AU2002353764A patent/AU2002353764A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003020875A2 (en) | 2003-03-13 |
| WO2003020875A3 (en) | 2003-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002236159A1 (en) | Immunogenic complex | |
| AU2002254558A1 (en) | Novel vaccine | |
| AU2002353764A1 (en) | Staphylococci surface-exposed immunogenic polypeptides | |
| AU2001284418A1 (en) | Novel polypeptide | |
| AU2003228863A1 (en) | Immunogenic peptides | |
| AU2002305903A1 (en) | Carbohydrate-associated proteins | |
| AU2002241899A1 (en) | Tip39 polypeptides | |
| AU2002343489A1 (en) | Nociceptin-based analgesics | |
| AU2002236160A1 (en) | Immunogenic complex comprising ribosomes | |
| AU2002349281A1 (en) | Rotating joint | |
| AU2002306879A1 (en) | Cytoskeleton-associated proteins | |
| AU2002224056A1 (en) | Novel polypeptide | |
| AUPR975401A0 (en) | Antigenic polypeptide | |
| AU2002328853A1 (en) | Carcinoma-related peptides | |
| AU2002244920A1 (en) | Hcv-binding polypeptides | |
| GB0101739D0 (en) | Novel polypeptide | |
| AU2002253048A1 (en) | Novel vaccine | |
| AUPR440001A0 (en) | Vaccine | |
| AU2002337263A1 (en) | Anti-coronavirus vaccine | |
| AU2002302785A1 (en) | Vaccines | |
| AU2002243466A1 (en) | Cytoskeleton-associated proteins | |
| GB0118825D0 (en) | Antigenic polypeptides | |
| AUPR223600A0 (en) | Antigenic polypeptide | |
| AU2002362917A1 (en) | Cyclone | |
| AUPR712301A0 (en) | The rotating skylight |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |